Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Maternal Tdap vaccination during pregnancy reduces pertussis risk in infants

Among infants of women who received the Tdap pertussis booster vaccine during pregnancy, the risk of contracting pertussis was reduced by an estimated 91 percent during the first two months of life - the critical period before they can receive their first childhood acellular pertussis (DTaP) vaccination.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.

31 Mar 2017

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection.

31 Mar 2017

Researchers find antibody to be effective against radiation-induced fibrosis

Radiation therapy is part of the treatment regimen for about two thirds of cancer patients today. Radiotherapy is well tolerated in most cases, but it can also lead to damage in healthy tissues that are also irradiated.

31 Mar 2017

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

ANGLE plc, the specialist medtech company, is delighted to announce that researchers from the Barts Cancer Institute, Queen Mary University of London, have presented new results at the World CDx Europe 2017 conference in London of their work with ANGLE’s Parsortix system in prostate cancer.

31 Mar 2017

Study shows new treatment pathway for antibiotic resistant bacteria and infectious diseases

A study, published in the American Journal of Respiratory and Critical Care Medicine, describes a new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and health care providers.

31 Mar 2017

New method for diagnosing flu virus from breath samples could provide faster results

A method for diagnosing flu virus from breath samples could soon replace invasive nasal swabs and deliver better results faster.

29 Mar 2017

Study explores new immunotherapy combinations to treat prostate cancer

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

29 Mar 2017

TSRI scientists develop novel method to analyze glycan shield on HIV’s glycoprotein

HIV is a master of disguise. The virus uses a shield of sugar molecules, called glycans, to hide from the immune system and block antibodies from attacking it.

28 Mar 2017

One-shot vaccine passes key preclinical test in newborn monkey models

Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.

24 Mar 2017

Penn researcher receives $16.3 million NIAID grant to develop long-sought-after HIV vaccine

Building on earlier work in designing chimeric human-simian immunodeficiency viruses (SHIVs) that serve as a model of HIV infection of humans, George M. Shaw, MD, PhD, a professor of Hematology/Oncology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania, has received $16.3 million over five years from the National Institute of Allergy and Infectious Diseases to develop a long-sought-after HIV vaccine.

22 Mar 2017

MIT researchers devise new strategy to make tumor cells more susceptible to cancer treatment

MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs.

20 Mar 2017

New study provides reassuring information about safety of osteoporosis drug

A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.

17 Mar 2017

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.

17 Mar 2017

TSRI researchers develop novel drug delivery method for treating cancers

Scientists from the Florida campus of The Scripps Research Institute have developed a new drug delivery method that produces strong results in treating cancers in animal models, including some hard-to-treat solid and liquid tumors.

16 Mar 2017

Study shows how mutations allow HCV to elude immune responses and vaccines

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide.

16 Mar 2017

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.

16 Mar 2017

Antibody treats pediatric brain tumors safely and effectively in mice

Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.

15 Mar 2017

New technique opens door for biochemists to create better therapeutic antibodies

Antibodies are the foot soldiers of our immune system. These specialized, Y-shaped proteins attach to bacteria and viruses, where they either block the pathogen's activity directly, or signal the immune system's cells to destroy the invader.

14 Mar 2017

Antibody News and Research

Further Reading

Maternal Tdap vaccination during pregnancy reduces pertussis risk in infants

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Researchers find antibody to be effective against radiation-induced fibrosis

ANGLE’s Parsortix system could help predict metastasis in prostate cancer

Study shows new treatment pathway for antibiotic resistant bacteria and infectious diseases

New method for diagnosing flu virus from breath samples could provide faster results

Study explores new immunotherapy combinations to treat prostate cancer

TSRI scientists develop novel method to analyze glycan shield on HIV’s glycoprotein

One-shot vaccine passes key preclinical test in newborn monkey models

Penn researcher receives $16.3 million NIAID grant to develop long-sought-after HIV vaccine

MIT researchers devise new strategy to make tumor cells more susceptible to cancer treatment

New study provides reassuring information about safety of osteoporosis drug

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

TSRI researchers develop novel drug delivery method for treating cancers

Study shows how mutations allow HCV to elude immune responses and vaccines

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

Antibody treats pediatric brain tumors safely and effectively in mice

New technique opens door for biochemists to create better therapeutic antibodies

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo